Staff editor
Microbiomepost discussed with Nicasio Mancini about the role of gut microbiome in immune response and in the antibiotic resistance.
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology, which provides greater…
First and only FDA-approved orally administered microbiota-based therapeutic, validating Seres’ microbiome platform –
Microbiomepost discussed with Vanessa Harris during the MicrobiotaMI congress 2023 about viral interaction with gut microbiome.
The VE303 study would be the first pivotal Phase 3 study of a therapeutic candidate based on a defined bacterial consortium, which Vedanta is pioneering as a next-generation approach to…
Watch the mode of action video to understand how this solution works to positively affect the natural balance between bone formation and bone resorption.
Maria Rescigno, professor at Humanitas University, discusses with MicrobioomePost what emerged at MicrobiotaMI congress 2023.
The bacterial strains in MB097 were identified by analysing the microbiome of patients in multiple studies of ICIs in melanoma.
Industry, Video
Sponsored by
Marco Caspani, Executive Director of the Microbiome Division of Sacco System, explains how the company is directing his efforts and strong focus to the field of Biotherapeutics with the launch of…
The first-in-human study double-blind, placebo controlled, 28-day crossover study of the safety and tolerability of SB-121
